Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1994 Jun 18;308(6944):1615–1619. doi: 10.1136/bmj.308.6944.1615

Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?

A D Struthers 1
PMCID: PMC2540431  PMID: 8025431

Full text

PDF
1615

Images in this article

1618p1618-a
on p.1618

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman M. H., Madhavan S., Ooi W. L., Cohen H., Sealey J. E., Laragh J. H. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 1991 Apr 18;324(16):1098–1104. doi: 10.1056/NEJM199104183241605. [DOI] [PubMed] [Google Scholar]
  2. Bevan E. G., Connell J. M., Doyle J., Carmichael H. A., Davies D. L., Lorimer A. R., McInnes G. T. Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension. J Hypertens. 1992 Jul;10(7):607–613. [PubMed] [Google Scholar]
  3. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., Luc G., Bard J. M., Bara L., Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 Oct 15;359(6396):641–644. doi: 10.1038/359641a0. [DOI] [PubMed] [Google Scholar]
  4. Chu A., Morris K. G., Kuehl W. D., Cusma J., Navetta F., Cobb F. R. Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. Circulation. 1989 Dec;80(6):1627–1635. doi: 10.1161/01.cir.80.6.1627. [DOI] [PubMed] [Google Scholar]
  5. Davidson N. C., Struthers A. D. Brain natriuretic peptide. J Hypertens. 1994 Apr;12(4):329–336. [PubMed] [Google Scholar]
  6. Hu D. C., Wong E. F., Wong N. L. The differential response in atrial natriuretic peptide release during exercise in patients with and without ischemic heart disease. Am J Med Sci. 1988 Aug;296(2):111–113. doi: 10.1097/00000441-198808000-00007. [DOI] [PubMed] [Google Scholar]
  7. Itoh H., Pratt R. E., Ohno M., Dzau V. J. Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension. 1992 Jun;19(6 Pt 2):758–761. doi: 10.1161/01.hyp.19.6.758. [DOI] [PubMed] [Google Scholar]
  8. Jamison R. L., Canaan-Kühl S., Pratt R. The natriuretic peptides and their receptors. Am J Kidney Dis. 1992 Nov;20(5):519–530. doi: 10.1016/s0272-6386(12)70269-x. [DOI] [PubMed] [Google Scholar]
  9. Kangawa K., Matsuo H. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun. 1984 Jan 13;118(1):131–139. doi: 10.1016/0006-291x(84)91077-5. [DOI] [PubMed] [Google Scholar]
  10. Lang C. C., Choy A. M., Pringle T. H., McNeill G. P., McAlpine H. M., Sturrock N. D., Struthers A. D. Renal, hemodynamic and neurohormonal effects of atrial natriuretic factor in cardiac allograft recipients treated with cyclosporin A. Am J Cardiol. 1993 Nov 1;72(14):1083–1084. doi: 10.1016/0002-9149(93)90868-d. [DOI] [PubMed] [Google Scholar]
  11. Lang C. C., Choy A. M., Struthers A. D. Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. Clin Sci (Lond) 1992 Nov;83(5):519–527. doi: 10.1042/cs0830519. [DOI] [PubMed] [Google Scholar]
  12. Lang C. C., Henderson I. S., Mactier R., Stewart W. K., Struthers A. D. Atrial natriuretic factor improves renal function and lowers systolic blood pressure in renal allograft recipients treated with cyclosporin A. J Hypertens. 1992 May;10(5):483–488. doi: 10.1097/00004872-199205000-00012. [DOI] [PubMed] [Google Scholar]
  13. Lerman A., Gibbons R. J., Rodeheffer R. J., Bailey K. R., McKinley L. J., Heublein D. M., Burnett J. C., Jr Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet. 1993 May 1;341(8853):1105–1109. doi: 10.1016/0140-6736(93)93125-k. [DOI] [PubMed] [Google Scholar]
  14. Monopoli A., Forlani A., Ongini E. Chronic inhibition of neutral endopeptidase reduces left ventricular hypertrophy without changing blood pressure in spontaneously hypertensive rats. J Hypertens Suppl. 1991 Dec;9(6):S246–S247. [PubMed] [Google Scholar]
  15. Motwani J. G., McAlpine H., Kennedy N., Struthers A. D. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet. 1993 May 1;341(8853):1109–1113. doi: 10.1016/0140-6736(93)93126-l. [DOI] [PubMed] [Google Scholar]
  16. Nakao K., Ogawa Y., Suga S., Imura H. Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides. J Hypertens. 1992 Sep;10(9):907–912. [PubMed] [Google Scholar]
  17. Pacher R., Globits S., Bergler-Klein J., Teufelsbauer H., Wutte M., Baumgartner W., Ogris E., Glogar D. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages. Eur Heart J. 1993 Feb;14(2):273–278. doi: 10.1093/eurheartj/14.2.273. [DOI] [PubMed] [Google Scholar]
  18. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  19. Struthers A. D. Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations? Br Heart J. 1993 Nov;70(5):397–398. doi: 10.1136/hrt.70.5.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sudoh T., Kangawa K., Minamino N., Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988 Mar 3;332(6159):78–81. doi: 10.1038/332078a0. [DOI] [PubMed] [Google Scholar]
  21. Sudoh T., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1990 Apr 30;168(2):863–870. doi: 10.1016/0006-291x(90)92401-k. [DOI] [PubMed] [Google Scholar]
  22. Tanaka H., Yasue H., Yoshimura M., Morita E., Jougasaki M., Kato H., Miyao Y., Nakao K. Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectoris. Am J Cardiol. 1993 Jul 15;72(2):128–133. doi: 10.1016/0002-9149(93)90147-5. [DOI] [PubMed] [Google Scholar]
  23. Wheeldon N. M., MacDonald T. M., Flucker C. J., McKendrick A. D., McDevitt D. G., Struthers A. D. Echocardiography in chronic heart failure in the community. Q J Med. 1993 Jan;86(1):17–23. [PubMed] [Google Scholar]
  24. Wilkins M. R., Unwin R. J., Kenny A. J. Endopeptidase-24.11 and its inhibitors: potential therapeutic agents for edematous disorders and hypertension. Kidney Int. 1993 Feb;43(2):273–285. doi: 10.1038/ki.1993.44. [DOI] [PubMed] [Google Scholar]
  25. Yoshibayashi M., Kamiya T., Saito Y., Matsuo H. Increased plasma levels of brain natriuretic peptide in hypertrophic cardiomyopathy. N Engl J Med. 1993 Aug 5;329(6):433–434. doi: 10.1056/nejm199308053290614. [DOI] [PubMed] [Google Scholar]
  26. van den Meiracker A. H., Man in 't Veld A. J., Admiraal P. J., Ritsema van Eck H. J., Boomsma F., Derkx F. H., Schalekamp M. A. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? J Hypertens. 1992 Aug;10(8):803–812. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES